201 related articles for article (PubMed ID: 19635861)
1. Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage.
Beraza N; Malato Y; Sander LE; Al-Masaoudi M; Freimuth J; Riethmacher D; Gores GJ; Roskams T; Liedtke C; Trautwein C
J Exp Med; 2009 Aug; 206(8):1727-37. PubMed ID: 19635861
[TBL] [Abstract][Full Text] [Related]
2. Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout.
Ehlken H; Krishna-Subramanian S; Ochoa-Callejero L; Kondylis V; Nadi NE; Straub BK; Schirmacher P; Walczak H; Kollias G; Pasparakis M
Cell Death Differ; 2014 Nov; 21(11):1721-32. PubMed ID: 24971483
[TBL] [Abstract][Full Text] [Related]
3. Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis.
Beraza N; Ofner-Ziegenfuss L; Ehedego H; Boekschoten M; Bischoff SC; Mueller M; Trauner M; Trautwein C
Gut; 2011 Mar; 60(3):387-96. PubMed ID: 21115542
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of natural killer cells protects the liver against acute injury in the absence of glycine N-methyltransferase.
Gomez-Santos L; Luka Z; Wagner C; Fernandez-Alvarez S; Lu SC; Mato JM; Martinez-Chantar ML; Beraza N
Hepatology; 2012 Aug; 56(2):747-59. PubMed ID: 22392635
[TBL] [Abstract][Full Text] [Related]
5. TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse.
Kahraman A; Barreyro FJ; Bronk SF; Werneburg NW; Mott JL; Akazawa Y; Masuoka HC; Howe CL; Gores GJ
Hepatology; 2008 Apr; 47(4):1317-30. PubMed ID: 18220275
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury.
Beraza N; Lüdde T; Assmus U; Roskams T; Vander Borght S; Trautwein C
Gastroenterology; 2007 Jun; 132(7):2504-17. PubMed ID: 17570222
[TBL] [Abstract][Full Text] [Related]
7. NF-κB essential modifier is required for hepatocyte proliferation and the oval cell reaction after partial hepatectomy in mice.
Malato Y; Ehedego H; Al-Masaoudi M; Cubero FJ; Bornemann J; Gassler N; Liedtke C; Beraza N; Trautwein C
Gastroenterology; 2012 Dec; 143(6):1597-1608.e11. PubMed ID: 22922425
[TBL] [Abstract][Full Text] [Related]
8. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
[TBL] [Abstract][Full Text] [Related]
9. CXCR6 protects from inflammation and fibrosis in NEMO
Liepelt A; Wehr A; Kohlhepp M; Mossanen JC; Kreggenwinkel K; Denecke B; Costa IG; Luedde T; Trautwein C; Tacke F
Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):391-402. PubMed ID: 30476545
[TBL] [Abstract][Full Text] [Related]
10. TNFR1 determines progression of chronic liver injury in the IKKγ/Nemo genetic model.
Cubero FJ; Singh A; Borkham-Kamphorst E; Nevzorova YA; Al Masaoudi M; Haas U; Boekschoten MV; Gassler N; Weiskirchen R; Muller M; Liedtke C; Trautwein C
Cell Death Differ; 2013 Nov; 20(11):1580-92. PubMed ID: 23933814
[TBL] [Abstract][Full Text] [Related]
11. Liver NK cells expressing TRAIL are toxic against self hepatocytes in mice.
Ochi M; Ohdan H; Mitsuta H; Onoe T; Tokita D; Hara H; Ishiyama K; Zhou W; Tanaka Y; Asahara T
Hepatology; 2004 May; 39(5):1321-31. PubMed ID: 15122761
[TBL] [Abstract][Full Text] [Related]
12. Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma.
Luedde T; Beraza N; Kotsikoris V; van Loo G; Nenci A; De Vos R; Roskams T; Trautwein C; Pasparakis M
Cancer Cell; 2007 Feb; 11(2):119-32. PubMed ID: 17292824
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-related apoptosis-inducing ligand on NK cells protects from hepatic ischemia-reperfusion injury.
Fahrner R; Trochsler M; Corazza N; Graubardt N; Keogh A; Candinas D; Brunner T; Stroka D; Beldi G
Transplantation; 2014 Jun; 97(11):1102-9. PubMed ID: 24804996
[TBL] [Abstract][Full Text] [Related]
14. Proteasome inhibitors enhance TRAIL-induced apoptosis through the intronic regulation of DR5: involvement of NF-kappa B and reactive oxygen species-mediated p53 activation.
Chen JJ; Chou CW; Chang YF; Chen CC
J Immunol; 2008 Jun; 180(12):8030-9. PubMed ID: 18523266
[TBL] [Abstract][Full Text] [Related]
15. Roles of CCR2 and CCR5 for Hepatic Macrophage Polarization in Mice With Liver Parenchymal Cell-Specific NEMO Deletion.
Bartneck M; Koppe C; Fech V; Warzecha KT; Kohlhepp M; Huss S; Weiskirchen R; Trautwein C; Luedde T; Tacke F
Cell Mol Gastroenterol Hepatol; 2021; 11(2):327-347. PubMed ID: 32896623
[TBL] [Abstract][Full Text] [Related]
16. Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity.
Mirandola P; Ponti C; Gobbi G; Sponzilli I; Vaccarezza M; Cocco L; Zauli G; Secchiero P; Manzoli FA; Vitale M
Blood; 2004 Oct; 104(8):2418-24. PubMed ID: 15205263
[TBL] [Abstract][Full Text] [Related]
17. TRAIL but not FasL and TNFα, regulates IL-33 expression in murine hepatocytes during acute hepatitis.
Arshad MI; Piquet-Pellorce C; L'Helgoualc'h A; Rauch M; Patrat-Delon S; Ezan F; Lucas-Clerc C; Nabti S; Lehuen A; Cubero FJ; Girard JP; Trautwein C; Samson M
Hepatology; 2012 Dec; 56(6):2353-62. PubMed ID: 22961755
[TBL] [Abstract][Full Text] [Related]
18. NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis.
Kondylis V; Polykratis A; Ehlken H; Ochoa-Callejero L; Straub BK; Krishna-Subramanian S; Van TM; Curth HM; Heise N; Weih F; Klein U; Schirmacher P; Kelliher M; Pasparakis M
Cancer Cell; 2015 Nov; 28(5):582-598. PubMed ID: 26555174
[TBL] [Abstract][Full Text] [Related]
19. The enhanced expression of death receptor 5 (DR5) mediated by HBV X protein through NF-kappaB pathway is associated with cell apoptosis induced by (TNF-α related apoptosis inducing ligand) TRAIL in hepatoma cells.
Kong F; You H; Zhao J; Liu W; Hu L; Luo W; Hu W; Tang R; Zheng K
Virol J; 2015 Nov; 12():192. PubMed ID: 26577955
[TBL] [Abstract][Full Text] [Related]
20. Hepatic DR5 induces apoptosis and limits adenovirus gene therapy product expression in the liver.
Zhang HG; Xie J; Xu L; Yang P; Xu X; Sun S; Wang Y; Curiel DT; Hsu HC; Mountz JD
J Virol; 2002 Jun; 76(11):5692-700. PubMed ID: 11991997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
